DL-Carnitine

Suppliers

Names

[ CAS No. ]:
406-76-8

[ Name ]:
DL-Carnitine

[Synonym ]:
L-(-)-Carnitine
(-)-L-Carnitin
3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Hydroxide Inner Salt
L(-)-Carnitine
(R)-Carnitine
Carnitine, L-
3-Hydroxy-4-trimethylammoniobutanoate
UNII:S7UI8SM58A
(L-3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt
Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, L-
Carnitine DL-form
L-Carnitine
BICARNESINE
3-Hydroxy-4-(trimethylammonio)butanoate
Cardiogen
g-Trimethylammonium-b-hydroxybutirate
4-Copab
Monocamin
L-Carnitine inner salt
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt
g-Trimethyl-b-hydroxybutyrobetaine
(-)-Carnitine
(3R)-3-Hydroxy-4-(trimethylammonio)butanoate
DL-Carnitine
(-)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate
carnitine (L-form)
Levocarnitine
g-Amino-b-hydroxybutyric Acid Trimethylbetaine
(R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide inner salt
(−)-(R)-3-Hydroxy-4-(trimethylammonio)butyrate
γ-Trimethyl-β-hydroxybutyrobetaine
Carnitine, (-)-
D,L-carnitine
(±)-carnitine
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (2R)-
carnitine

Chemical & Physical Properties

[ Molecular Formula ]:
C7H15NO3

[ Molecular Weight ]:
161.199

[ Exact Mass ]:
161.105194

[ PSA ]:
60.36000

[ LogP ]:
-4.52

[ Storage condition ]:
2-8℃

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
BP2979900
CHEMICAL NAME :
Ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, DL-
CAS REGISTRY NUMBER :
406-76-8
LAST UPDATED :
198912
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C7-H15-N-O3
MOLECULAR WEIGHT :
161.23
WISWESSER LINE NOTATION :
QV1YQ1K1&1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
13500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ABMGAJ Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. Volume(issue)/page/year: 3,28,1959
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
995 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2008578
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
11500 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - fluid intake Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
ABMGAJ Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. Volume(issue)/page/year: 3,28,1959
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
610 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2008578

Safety Information

[ HS Code ]:
2923900090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Chloroacetaldehyde
  • ketene
  • Trimethylamine
  • (S)-3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium 4-methylbenzenesulfonate
  • Ethyl 4-bromo-3-hydroxybutanoate
  • DL-γ-Amino-β-hydroxybutyric acid
  • methyl iodide
  • DL-Carnitine
  • [()-(4-amino-2-hydroxy-4-oxobutyl)trimethylammonium] chloride

DownStream

  • UNII:0M94O5FN60

Customs

[ HS Code ]: 2923900090

[ Summary ]:
2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

Related Compounds

  • DL-Carnitine
  • DL-CARNITINE
  • DL-Carnitine
  • DL-CARNITINEOROTATE
  • Acetyl-DL-carnitine
  • ACETYL-DL-CARNITINE
  • N-{2-[4-(dimethylamino)phenyl]ethyl}-1,3,5-trimethyl-1H-pyrazole-4-sulfonamide
  • [(1R,3S,5R,7S,9R,11S,13R,14S,16R,18S,20R,22S,25R,27S,30S,31R,33S,34R,35R,37S,40S,42R,44S,46R,48S)-34-hydroxy-40-[(2R,3E)-2-hydroxyhexa-3,5-dien-2-yl]-13,25,27,30,35-pentamethyl-39-methylidene-13-(2-sulfooxyethyl)-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.03,25.05,22.07,20.09,18.011,16.031,48.033,46.035,44.037,42]nonatetracontan-14-yl] hydrogen sulfate
  • 3-Bromo-5-methyl-1-benzofuran
  • Benzamide, N-[4-[[5-(cyclohexylmethyl)-1H-pyrazol-3-yl]amino]-4-oxobutyl]-2,4-difluoro-
  • 3-(Dimethyl-1,3-thiazol-4-yl)propan-1-ol
  • 7-Fluoro-1-methyl-1H-indole
  • N-(1-cyano-1,2-dimethylpropyl)-2-(2,2,4-trioxo-3,4-dihydro-1H-2lambda6,3-benzothiazin-3-yl)acetamide
  • N,N-bis(cyanomethyl)-3-[(2,3-dihydro-1H-inden-1-yl)(prop-2-yn-1-yl)amino]propanamide
  • N-(1-cyano-1,2-dimethylpropyl)-2-{methyl[(4-methylquinazolin-2-yl)methyl]amino}acetamide
  • 4-(Bromofluoromethyl)benzotrifluoride
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.